The largest database of trusted experimental protocols

Anti mir 372

Manufactured by Thermo Fisher Scientific
Sourced in United States

Anti-miR-372 is a synthetic oligonucleotide designed to inhibit the function of microRNA-372. It can be used in research applications to study the role of microRNA-372 in cellular processes.

Automatically generated - may contain errors

2 protocols using anti mir 372

1

Wound Healing and Cell Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 10 μl pipette tip was used to generate an artificial wound onto confluent cell monolayers of control or Adeno-SM transduced MDA-MB-231 cells. The cell migration was then observed in serum containing medium upto 24 hours of the above mentioned treatments(s). Images were taken at 37 °C using Motorized IX-81 inverted microscope attached with DP70 CCD camera (Nikon). The distance migrated towards the wound was calculated after 90 minutes. MDA-MB-231 cells, alone or overexpressed with different pCMV-miR constructs or knocked down using antagomiRs in combination with SMAR1 over expression (Adeno-SM) or SMAR1 knockdown (sh1077 construct) were added to the upper chamber of the Boyden chamber (Corning). AntagomiRs used in the assay were anti-miR-371-3p, anti-miR-371-5p, anti-miR-372, anti-miR-373 and anti-miR-negative control (Ambion). The cells migrated to the reverse side of the upper chamber were fixed and stained with Crystal violet and counted under an inverted microscope (Nikon). Data are represented as the average of five fields per treatment well.
+ Open protocol
+ Expand
2

ULK1 Overexpression and miR-372 Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with anti‐miR‐372 (Ambion, Austin, TX, USA) or miR‐372 mimic using the reverse transfection method using the siPORTTM NeoFXTM transfection reagent (Ambion). The siRNA targeting human ULK1 (si‐ULK1) and the corresponding negative control were purchased from GenePharma (Shanghai, China). ULK1 overexpressing plasmids were constructed using pCDNA3.1 (+) basic vectors in our laboratory. These were transfected into BXPC‐3 and PANC‐1 cells with 80%–90% confluence, using Lipofectamine 2000 (Invitrogen, USA), according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!